Lv71
4985 积分 2021-05-12 加入
Progression-free survival estimates are shaped by specific censoring rules: Implications for PFS as an endpoint in cancer randomized trials
4小时前
已完结
Addressing Uneven Treatment Discontinuation Rate in the Chemotherapy Arm of the EV-302 Phase 3 Randomized Clinical Trial: Implications for Outcome Interpretation
5小时前
已完结
Family-wise type I error rate control for an extended 2-in-1 design with graphical approach in oncology drug development
2个月前
已完结
2-in-1 adaptive design with dose optimization accounting for ranked dose response
2个月前
已完结
An adaptive seamless 2-in-1 design with biomarker-driven subgroup enrichment
2个月前
已完结
An extension to a 2-in-1 adaptive design with biomarker subpopulation selection
2个月前
已完结
Flexible seamless 2-in-1 design with sample size adaptation
2个月前
已完结
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
3个月前
已完结
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
4个月前
已完结
Sample size determination for cardiodynamic ECG assessment using the Concentration-QTc analysis method
4个月前
已完结
皖公网安备34019202002308
